Skip to Main Content

Paper Details

MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities.
Cancers (Basel)
9
2023
Author NameAffiliation
Jianjun ZhangThe University of Texas MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2